We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Automated Test for Troponin-I

By HospiMedica staff writers
Posted on 08 Sep 2004
A test for troponin-I (TnI) is now available for use on the automated Architect i2000SR immunoassay system and the Architect ci8200 immunochemistry system of Abbott Laboratories (Abbott Park, IL, USA). More...
The test has been cleared by the U.S. Food and Drug Administration (FDA).

Troponins are a complex of regulatory proteins present on striated muscle that regulate the calcium-mediated interaction of actin and myosin. TnI is a protein released from dead or severely injured heart muscle cells following a cardiac event. Providing stat results within 18 minutes, the Architect i2000SR can perform up to 200 tests per hour. The stat functionality enables rapid turnaround time of TnI results, enabling doctors to quickly diagnose and treat patients with chest pain.

"Based on the American College of Cardiology's new criteria for diagnosing myocardial infarction, troponin has become the gold standard in diagnostic testing,” noted Michael S. Parmacek, M.D., chief of cardiovascular medicine, University of Pennsylvania (Philadelphia, USA).

Combining immunoassay and clinical chemistry on one integrated platform, the ci8200 system runs up to 200 immunoassay tests and up to 1,200 clinical chemistry tests an hour. By consolidating both testing capabilities, the ci8200 helps improve laboratory productivity and efficiency. When running tests to aid the diagnosis of chest pain, tests can be run concurrently, supplying doctors with the rapid results they need to diagnose a potential cardiac event and determine the best course of treatment.




Related Links:
Abbott

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Blood Bank Refrigerator
MBR-705GR-PE
Pulmonary Ventilator
OXYMAG
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.